Capital International Investors Johnson & Johnson Transaction History

Capital International Investors

$483 Billion
Q1 2024

A detailed history of Capital International Investors transactions in Johnson & Johnson stock. As of the latest transaction made, Capital International Investors holds 17,155,881 shares of JNJ stock, worth $2.52 Billion. This represents 0.56% of its overall portfolio holdings.

Number of Shares

17,155,881

Previous 28,985,676 40.81%

Holding current value

$2.52 Billion

Previous $4.54 Billion 40.27%

% of portfolio

0.56%

Previous 1.04%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$155.22 - $162.74 $1.84 Billion - $1.93 Billion	-11,829,795 Reduced 40.81%	17,155,881 $2.71 Billion
Q4 2023 Feb 13, 2024	SELL	$145.6 - $158.88 $79,060 - $86,271	-543 Reduced -0.0%	28,985,676 $4.54 Billion
Q3 2023 Nov 13, 2023	BUY	$155.75 - $174.48 $181 Million - $202 Million	1,160,424 Added 4.17%	28,986,219 $4.51 Billion
Q2 2023 Aug 11, 2023	BUY	$154.35 - $166.11 $1.66 Billion - $1.78 Billion	10,724,110 Added 62.71%	27,825,795 $4.61 Billion
Q1 2023 May 15, 2023	SELL	$151.05 - $180.26 $70.7 Million - $84.4 Million	-467,969 Reduced 2.66%	17,101,685 $2.65 Billion

Q4 2022 Feb 14, 2023	SELL	$160.2 - $179.79 $194 Million - $218 Million	-1,212,751 Reduced 6.46%	17,569,654 $3.1 Billion
Q3 2022 Nov 14, 2022	SELL	$161.33 - $179.52 $118 Million - $131 Million	-728,840 Reduced 3.74%	18,782,405 $3.07 Billion
Q2 2022 Aug 15, 2022	SELL	$168.19 - $186.01 $87.7 Million - $97 Million	-521,705 Reduced 2.6%	19,511,245 $3.46 Billion
Q1 2022 May 16, 2022	SELL	$158.14 - $179.59 $27.4 Million - $31.1 Million	-173,269 Reduced 0.86%	20,032,950 $3.55 Billion
Q4 2021 Feb 14, 2022	SELL	$155.93 - $173.01 $57 Million - $63.2 Million	-365,411 Reduced 1.78%	20,206,219 $3.46 Billion
Q3 2021 Nov 15, 2021	BUY	$161.5 - $179.47 $229 Million - $254 Million	1,417,008 Added 7.4%	20,571,630 $3.32 Billion
Q2 2021 Aug 16, 2021	BUY	$159.48 - $171.07 $139 Million - $149 Million	868,659 Added 4.75%	19,154,622 $3.16 Billion
Q1 2021 May 14, 2021	BUY	$153.07 - $170.48 $2.1 Million - $2.34 Million	13,703 Added 0.07%	18,285,963 $3.01 Billion
Q4 2020 Feb 12, 2021	BUY	$137.11 - $157.38 $1.63 Million - $1.87 Million	11,904 Added 0.07%	18,272,260 $2.88 Billion
Q3 2020 Nov 13, 2020	BUY	$140.38 - $153.83 $2.42 Million - $2.66 Million	17,262 Added 0.09%	18,260,356 $2.72 Billion
Q2 2020 Aug 14, 2020	BUY	$128.81 - $155.51 $195 Million - $236 Million	1,516,129 Added 9.06%	18,243,094 $2.57 Billion
Q1 2020 May 15, 2020	BUY	$111.14 - $153.99 $223 Million - $309 Million	2,004,688 Added 13.62%	16,726,965 $2.19 Billion
Q4 2019 Feb 18, 2020	SELL	$127.5 - $146.44 $624 Million - $717 Million	-4,898,022 Reduced 24.96%	14,722,277 $2.15 Billion
Q3 2019 Nov 14, 2019	SELL	$126.95 - $142.14 $302 Million - $338 Million	-2,375,078 Reduced 10.8%	19,620,299 $2.54 Billion
Q2 2019 Aug 14, 2019	SELL	$131.15 - $144.24 $80.1 Million - $88.1 Million	-610,880 Reduced 2.7%	21,995,377 $3.06 Billion
Q1 2019 May 15, 2019	SELL	$125.72 - $139.79 $304 Million - $338 Million	-2,417,554 Reduced 9.66%	22,606,257 $3.16 Billion
Q4 2018 Feb 14, 2019	BUY	$122.84 - $147.84 $4.86 Million - $5.85 Million	39,562 Added 0.16%	25,023,811 $3.23 Billion
Q3 2018 Nov 14, 2018	BUY	$121.58 - $142.88 $2.28 Billion - $2.68 Billion	18,768,905 Added 301.98%	24,984,249 $3.45 Billion
Q2 2018 Aug 14, 2018	BUY	$119.4 - $131.76 $16,954 - $18,709	142 Added 0.0%	6,215,344 $754 Million
Q1 2018 May 15, 2018	BUY	$125.1 - $148.14 $12.1 Million - $14.4 Million	96,999 Added 1.59%	6,215,202 $796 Million
Q4 2017 Feb 14, 2018	BUY	$131.22 - $143.62 $84.2 Million - $92.1 Million	641,400 Added 11.71%	6,118,203 $855 Million
Q3 2017 Nov 14, 2017	BUY	$129.47 - $135.38 $709 Million - $741 Million	5,476,803	5,476,803 $712 Million

Others Institutions Holding JNJ

# of Institutions

4,139

Shares Held

1.64B

Call Options Held

15.1M

Put Options Held

12.1M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $383B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital International Investors with notifications on news.

Account

Capital International Investors Johnson & Johnson Transaction History